Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01698294 · ClinicalTrials.gov registry record · NA
Biomarkers in Post-Menopausal Women Receiving Flaxseed
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 258
- Enrollment target
NCT01698294 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 258 participants.
The verdict
NCT01698294, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 258 participants
- Enrollment target
Study Summary
This randomized clinical trial studies biomarkers in post-menopausal women receiving flaxseed. Studying samples of blood, urine, and feces in the laboratory from participants receiving flaxseed may help doctors understand the effects of flaxseed on biomarkers.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
- OTHER Clinical Observation
- DIETARY_SUPPLEMENT Flaxseed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2012-12-14 |
| Est. Completion | 2017-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01698294
The ClinicalTrials.gov registry entry for NCT01698294 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01698294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01698294 about?
NCT01698294 is a clinical study titled "Biomarkers in Post-Menopausal Women Receiving Flaxseed". This randomized clinical trial studies biomarkers in post-menopausal women receiving flaxseed. Studying samples of blood, urine, and feces in the laboratory from participants receiving flaxseed may help doctors understand the effects of flaxseed on biomarkers.
What is the current status of trial NCT01698294?
This trial is currently completed. It is a NA study. The enrollment target is 258 participants. The study started on 2012-12-14. Estimated completion is 2017-06-08.
What interventions are being tested in trial NCT01698294?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Clinical Observation (OTHER), Flaxseed (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01698294?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.